Voltaren and Haloperidol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Voltaren (diclofenac sodium) and Haloperidol (haloperidol). Common drug interactions include chest pain among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Voltaren and Haloperidol. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Voltaren?

Voltaren has active ingredients of diclofenac sodium. It is often used in arthritis. eHealthMe is studying from 82,346 Voltaren users. Check the latest studies of Voltaren.

What is Haloperidol?

Haloperidol has active ingredients of haloperidol. It is often used in schizophrenia. eHealthMe is studying from 16,637 Haloperidol users. Check the latest studies of Haloperidol.



On Aug, 11, 2026

45 people who take Voltaren and Haloperidol together, and have interactions are studied.

Voltaren and Haloperidol drug interactions.

What are the common drug interactions of Voltaren and Haloperidol, by gender? *:

female:

  1. Chest pain
  2. Chronic kidney disease
  3. Dementia (madness)
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Headache (pain in head)
  6. Insomnia (sleeplessness)
  7. Poor venous access
  8. Abdominal distension
  9. Abdominal pain
  10. Abdominal pain lower

male:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Pneumonia
  3. Blood pressure decreased
  4. Liver disorder (liver diseases)
  5. Pleural haemorrhage (bleeding into the membranes around the lungs)
  6. Rash
  7. Renal failure acute (rapid kidney dysfunction)
  8. Renal tubular necrosis (death of kidney tubules)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

What are the common drug interactions of Voltaren and Haloperidol, by age (0-1 to 60+)? *:

0-1:

  1. Liver disorder (liver diseases)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cholangitis (infection of the bile duct)
  2. Collapse of lung (functional breakdown of lung)
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Drug exposure during pregnancy
  5. Hyperglycaemia (high blood sugar)
  6. Stent occlusion (blockage of stent)

40-49:

  1. Blood bilirubin increased
  2. Blood pressure decreased
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Depressed level of consciousness
  6. Death
  7. Abnormal behaviour
  8. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  9. Cellulitis (infection under the skin)
  10. Confusional state

50-59:

  1. Staphylococcal infection (an infection with staphylococcus bacteria)
  2. Stress
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  5. Upper respiratory tract inflammation
  6. Viral rash
  7. Dehydration (dryness resulting from the removal of water)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Renal tubular necrosis (death of kidney tubules)
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

60+:

  1. Pneumonia
  2. Cerebral infarction (less blood supply to brain resulting tissue damage)
  3. Abnormal behaviour
  4. Anaemia (lack of blood)
  5. Blood brain barrier defect (blood brain barrier defect-this bbb defect causes the bbb to break down in many pathological situations eg around brain tumours and when there is inflammation in the cns)
  6. Blood culture positive
  7. Blood pressure decreased
  8. Brain abscess
  9. Bronchial haemorrhage (bleeding in bronchia)
  10. Completed suicide (act of taking one's own life)

What are the existing conditions these people have? *

  1. Pain: 7 people, 15.56%
  2. Fever: 6 people, 13.33%
  3. Constipation: 6 people, 13.33%
  4. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 8.89%
  5. Insomnia (sleeplessness): 4 people, 8.89%
  6. Upper Respiratory Tract Inflammation: 3 people, 6.67%
  7. Sedation: 3 people, 6.67%
  8. Neuralgia (pain in one or more nerves): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Voltaren and Haloperidol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Voltaren and Haloperidol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Voltaren:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Haloperidol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Voltaren and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Haloperidol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on diclofenac sodium and haloperidol (the active ingredients of Voltaren and Haloperidol, respectively), and Voltaren and Haloperidol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: